Acylin Therapeutics Inc - WA King, Seattle 98102

Acylin Therapeutics Inc entered the industry of Research and Development Laboratories in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 541712, which describes it as a Research and Development Laboratories. For further clarification, the SIC classifies this business under the code 8731 and described it as a Research and Development Laboratories. The business provides service to the B2B market.

To acquire more information, please contact Suresh Jain by calling (206) 957-7300 during business hours. You can also write to the business’ Branch at 1616 Eastlake Avenue East # 203, Seattle, Washington WA 98102. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Acylin Therapeutics Inc
Representative: Suresh Jain
Place of Business: 1616 Eastlake Avenue East # 203, Seattle, WA 98102
Contact Number: (206) 957-7300
Type of Service: Research and Development Laboratories
SIC Number: 8731
NAICS Number: 541712
Locality: Branch
Market Type: B2B (Business to Business)
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Acylin Therapeutics Inc is a company operating from King, Washington providing professional Research and Development Laboratories and relevant B2B variables. It was founded in 0 and registered with the SIC code 8731 as Research and Development Laboratories, and with the NAICS code 541712 as Research and Development Laboratories.

With a current employee count of 1 to 4, Acylin Therapeutics Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Suresh Jain at (206) 957-7300 for related queries, or to locate its Branch using the coordinates 47.634694,-122.32509.

The Branch can also be found at the street address 1616 Eastlake Avenue East # 203 in Seattle, Washington 98102 and can be engaged online through the company website at , the company Twitter , and Facebook page .